C. Pot

Discipline

Sociologie (2) Psychologie (2) Economies et finances (2) Science politique (1) Gestion et management (1) Education (1)

Type de document

Articles (41) Recensions (8) Prépublication (1)

Co-auteur

Date

Source

Mot-clé

Multiple sclerosis (27) Human beings (23) maladie (19) maladie (19) Treatment (17) Patients (17) Patients (17) âge (11) adulte (11) Age (11) Age (11) adulte (11) Diagnosis (10) Swiss (10) Persons (10) Older people (10) Disabilities (10) temps (durée) (9) Time (9) Diseases (9) Diagnosis (9) Central nervous system (9) Cells (9) Analysis (9) analyse (8) Inflammation (8) Example (8) risque (7) modèle (7) Symptoms (7)

Documents écrit par C. Pot (42) | parle de C. Pot (0)

25-Hydroxycholesterol attenuates tumor necrosis factor alpha-induced blood-brain barrier breakdown in vitro.
R.A. Loiola et al.
Increased central obesity correlates with physical activity and food processing in recently diagnosed multiple sclerosis.
G. Thévoz et al.
Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.
V. Loser et al. (22 juil. 2024)
Maladie du spectre des anticorps anti-MOG [Anti-MOG associated disease]
J. Lerusse et al. (24 avr. 2024)
Traitements de la sclérose en plaques : quand les arrêter ? [Discontinuing disease-modifying therapies in multiple sclerosis]
P.H. Lalive et al. (24 avr. 2024)
Traitements de la sclérose en plaques : mise à jour [Treatments for multiple sclerosis: update]
M. Uginet et al. (24 avr. 2024)
Closing the scissor-shaped curve: Strategies to promote gender equality in academia.
J.A. Joyce et al. (14 mars 2024)
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.
J. Oechtering et al.
Traitements de la sclérose en plaques en 2024.
C. Pot (24 janv. 2024)
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
A. Cagol et al. (9 janv. 2024)
La BOAT : un dispositif original de prévention des tempêtes liées aux violences à caractère sexuel et sexiste
M. Poitau et al. (2024)
Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseases.
A. Mathias et al. (2024)
25-Hydroxycholesterol in health and diseases.
C. Nguyen et al.
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
A.R. Todea et al.
Troubles cognitifs dans la sclérose en plaques : quand y penser ? [Cognitive impairment in multiple sclerosis: when to think about it?]
M. Perrenoud et al. (26 avr. 2023)
Endothelial cell-derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis.
F. Ruiz et al. (6 mars 2023)
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
A. Mathias et al.
The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial.
M. Papageorgiou et al.
The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing.
D. Chiavi et al. (10 nov. 2022)
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry.
M. Stanikić et al.
Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study.
C. Sieber et al. (5 oct. 2022)
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
J. Oechtering et al.
Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study.
C.O. Renaud et al. (21 mai 2022)
Discussing Challenges in Diagnosis of Tuberculous Meningitis and Neurosarcoidosis.
A. Santos et al.
Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis.
S. Vigne et al. (7 févr. 2022)

next